PRODUCTS
PRODUCTS
APIs and intermediates
PRODUCTS
Parecoxib sodium Intermediates
PRODUCTS
Crisaborole API & Intermedia… Topiroxostat API & Intermedi… Tavaborole API & Intermedia… Upadacitinib API & Intermed… BrexpiprazoleAPI & Intermedi… TEST Others Ticagrelor Intermediates Others Parecoxib sodium Intermediat… Canagliflozin Intermediates Empagliflozin Intermediates Dapagliflozin Intermediates Tofacitinib Intermediates Baricitinib Intermediates Baricitinib Intermediates Vonoprazan Fumarate Intermed… Febuxostat Intermediates Ceftaroline fosamil Interme… Rivaroxaban Intermediates Avatrombopag Intermediates Ramelteon Intermediates Pimavanserin Intermediates Intermediates of Carbapenems… Dabigatran etexilate Interme… Crisaborole Intermediates Finafloxacin Hydrochloride I… Meropenem Sacubitril Apixaban Intermediates Zolpidem tartrater Intermedi… Tolvaptan Intermediates Edoxaban Intermediates Nucleus and intermediates of… Acotiamide intermediates Apremilast intermediates Roxadustat intermediates Linagliptin intermediates Ibrutinib Intermediates Eltrombopag Intermediates Posaconazole Intermediates | Name | 5-Methyl-3,4-diphenylisoxazole |
| Purity | ≥99% |
| Appearance | White to off-white powder |
| Synonym | 3-Phenyl-4-(4-aMinosulfonylbenzyl)-5-Methylisoxazole,Valdecoxib IMpurity A |
| Cas No | 37928-17-9 |
| Molecular Formular | C16H13NO |
| Molecular Weight | 235.28 |
Structural Formula |  |
| Product Introduction | 5-Methyl-3,4-diphenylisoxazole[37928-17-9] is used as a raw material for the synthesis of parecoxib sodium |
| Product Status | 5-Methyl-3,4-diphenylisoxazole[37928-17-9].Our company has commercialized this product for long-term stable supply. |
| ??Product Quality | For futher detailed of 5-mthyl-3.4-diphenylisoxzole, please download the certification of analysis of [37928-17-9] |
Contact Information | If you are interested in 5-methyl-3, 4- diphenyl isooxazole [37928-17-9]，we will provide you with reasonable price, high quality products, looking forward to your contact. Telphone: +86-556-5032306 |
Copyright Bayeebio Biotech (Shanghai) Co., Ltd. Shanghai 滬ICP備16015574號
